De Sanctis V, Zurlo M G, Senesi E, Boffa C, Cavallo L, Di Gregorio F
Paediatric Division, Arcispedale S Anna, Ferrara.
Arch Dis Child. 1988 Jan;63(1):58-62. doi: 10.1136/adc.63.1.58.
Diabetes mellitus was observed in 29 of 448 patients with thalassaemia major attending seven Italian centres. Twelve patients, at onset of clinical diabetes, presented with an asymptomatic glycosuria, 13 with ketosis, and four with ketoacidosis. All were diagnosed after 1979, at a mean age of 17 years. Mean age at diagnosis of diabetes was lower in patients born in the last two decades. In these patients transfusions were started at a younger age and pre-transfusion haemoglobin concentration, serum ferritin concentration, incidence of liver disease, and the presence of a family history of diabetes were higher than in patients born previously. Although 27 (93%) cases had iron chelating treatment the mean serum ferritin concentration was 5600 micrograms/l; 25 (92%) of these patients had signs of liver impairment. The determination of C peptide in 10 patients showed a wide variation in pancreatic beta cell function, and insulin requirements ranged between 0.15 and 1.72 U/kg body weight. Metabolic control was generally poor. The onset of diabetes mellitus was followed in most patients by the appearance of other endocrine or cardiac complications, or both. Fourteen patients died within three years of presenting with overt diabetes. Haemosiderosis, liver infections, and genetic factors seemed to be crucial in diabetes development. Thalassaemic patients developing clinical diabetes mellitus are at high risk for other complications and should be strictly monitored, especially for thyroid impairment.
在七个意大利中心就诊的448例重型地中海贫血患者中,有29例观察到患有糖尿病。12例临床糖尿病发病患者表现为无症状性糖尿,13例有酮症,4例有酮症酸中毒。所有患者均于1979年后确诊,平均年龄为17岁。过去二十年出生的患者中糖尿病诊断时的平均年龄较低。在这些患者中,输血开始的年龄较小,输血前血红蛋白浓度、血清铁蛋白浓度、肝病发生率以及糖尿病家族史的存在情况均高于以前出生的患者。尽管27例(93%)患者接受了铁螯合治疗,但平均血清铁蛋白浓度仍为5600微克/升;其中25例(92%)患者有肝功能损害迹象。对10例患者的C肽测定显示胰腺β细胞功能差异很大,胰岛素需求量在0.15至1.72单位/千克体重之间。代谢控制总体较差。大多数患者糖尿病发病后出现了其他内分泌或心脏并发症,或两者皆有。14例患者在出现明显糖尿病后三年内死亡。含铁血黄素沉着症、肝脏感染和遗传因素似乎在糖尿病发展中起关键作用。发生临床糖尿病的地中海贫血患者发生其他并发症的风险很高,应进行严格监测,尤其是甲状腺功能损害。